• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·Taiwan·Healthcare·8409.TWO
Share

EBM Technologies Incorporated Stocks

NT$ 18.3Last Updated 29.07.2026

Issuer Rating

3/7
Performance

Average

Risk

Considerable

Recommendation

Sell

Market Cap

NT$ 18.56M

NT$ 18.3
Key Takeaways

Risk factor

Very poor trading liquidity

Data is available to registered users only
Data is available to registered users only

Profitability factor

Very low or no dividends

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

Established in 1988 and headquartered in Taipei, Taiwan, EBM Technologies Incorporated is dedicated to developing and commercializing sophisticated software and integrated solutions for the global healthcare sector. The company's core offerings include a comprehensive suite of Enterprise Picture Archiving and Communication Systems (PACS). This encompasses SoliPACS, designed to unify various radiology, mammography, and dental imaging products; SoliPACS Gateway for seamless DICOM communication; SoliPACS Server, acting as a crucial interface between hospital information systems (HIS), radiology information systems (RIS), and PACS; SoliPACS Web Viewer, enabling medical professionals to remotely access, compare, and utilize DICOM-compliant images; SoliPACS Report for generating customizable diagnostic reports; and the Advanced Server Archive for robust PACS data storage. EBM also leads in mobile diagnostic technology, featuring the UDE (Ubiquitous Diagnostic Environment) App, which transforms an iPad Pro into an all-in-one standalone DICOM server, viewer, display, and AI processing unit. Their extensive MobiPACS portfolio provides a complete mobile imaging ecosystem, including MobiPACS Server for storing and processing images on mobile devices, the MobiPACS App for on-the-go viewing, MobiPACS Web Viewer for accessing images from any internet-enabled device, MobiPACS Share for cloud-based collaboration, and MobiPACS Multi, which supports connecting multiple iPads/iPad Pros for integrated image display. Beyond imaging, EBM provides a range of specialized medical technologies. These include Vital-Sign On-the-Go for real-time patient monitoring; Rad@ for viewing medical-grade images and facilitating diagnoses; a Digital Pathology Scanner that converts physical slides into digital whole-slide images; the AgileRIS App for offline reporting; EPS Pi, a viewer-ready DICOM device; and the UniGate_i (UGI) App. Furthermore, the company delivers essential information management and eHealth solutions. These comprise Telemed, linking medical facilities for enhanced collaboration; Electronic Medical Records (EMR), providing digital versions of patients' medical histories; Personal Health Records (PHR), offering individuals electronic access to their health data; and broader eHealth solutions for retrieving and reviewing patient images, vital signs, and ECG waveforms.

Company Valuation

Slightly undervalued
5/7

From both historical and forecast perspectives, the stock is moderately underpriced compared to similar stocks. Specifically, the stock is fairly valued on P/E, undervalu

Data is available to registered users only
Sign up to access detailed valuation

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

Trending

30.07.2026 20:09

Meta Lost $100 Billion in Market Value Amid Zuckerberg's Attempts to Sell an AI Concept

30.07.2026 19:30

"Volatility Is the New Normal": Shell Posts Second-Highest Profit in Its History

30.07.2026 18:53

Microsoft and chipmakers boosted U.S. stocks: The Nasdaq 100 jumped nearly 3%

30.07.2026 18:25

Prof. services adviser CBIZ to be acquired by peer in largest such deal in 25 years

30.07.2026 17:53

U.S. economic growth slowed and fell short of expectations in the second quarter. What's next?

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn

Services

  • Stock Screener
  • Guru Portfolios
  • X (Twitter)
  • LinkedIn
Oninvest© 2026